Maxceed Capital
明越资本
elsewhere's corpus does not cover Maxceed Capital as a subject. The bundle contains no document chunks about the fund itself — only an entity card label and a handful of unrelated references where the name appears incidentally. No founding date, strategy, team, or portfolio details are available.
AI-generated — may contain errors, please verify.
Coverage
Source Code Capital | "Xijie Fried Skewers" Announces 75 Million Yuan Series A+ Funding Round, Source Code Capital Co-Led Series A Round
A highly standardized, normalized digital supply chain system.
Xijiezhachuan, a fried-skewer snack brand, announced the completion of a 295 million yuan Series A funding round led by Source Code Capital.
"Ten Thousand Stores in a Hundred Cities," dedicated to helping 100,000 Chinese people successfully realize their entrepreneurial dreams.
Source Code Capital portfolio company Galixir announced the completion of a new funding round, with existing shareholder Source Code Capital continuing to increase its stake.
Continuously exploring the application of AI technology to empower innovative drug R&D
5Y News | Galixir Completes New Strategic Funding Round, Continues Advancing Drug R&D Pipeline
5Y Capital continues to watch for opportunities where information technology can be applied in healthcare and medicine.
Galixir, a Source Code Capital portfolio company, raises tens of millions of dollars in funding, with existing investor Source Code Capital continuing to increase its stake
Galixir's technical capabilities are built on sophisticated AI models, enabling end-to-end coverage of drug discovery from hit compounds to preclinical candidates.
5Y News | Galixir Announces Completion of Tens of Millions of USD in Funding, with Continued Backing from 5Y Capital
Breaking the Bottleneck in New Drug R&D with "AI+"
